| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $2.31B | $1.70B | $1.08B | $820.22M | $625.49M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $624.11M | $404.14M | $320.68M | $316.42M | $264.21M |
| SG&A | $1.18B | $841.31M | $618.31M | $588.59M | $511.03M |
| Operating Income | -$309.91M | -$222.29M | -$446.25M | -$541.04M | -$468.17M |
| Interest Expense | $4.07M | $10.69M | $12.64M | $9.32M | $8.30M |
| Tax Expense | -$59.93M | $695.00K | $271.00K | $978.00K | $618.00K |
| Net Income | -$208.16M | -$190.43M | -$434.80M | -$547.80M | -$471.72M |
| EPS (basic) | -1.5200 | -1.5300 | -3.7800 | -5.5700 | -5.2100 |
| EPS (diluted) | -1.5200 | -1.5300 | -3.7800 | -5.5700 | -5.2100 |
| Shares (diluted) | $136.72M | $124.72M | $115.00M | $98.41M | $90.56M |